Semi-Compliant (FDA SOON)
Freeway
Balloon catheters and specialty devices engineered for improved and predictable coronary intervention.
Designed for physicians who demand performance, control, and reliability.
Explore our coronary and innovation portfolios — each product developed through clinical feedback and rigorous R&D to support complex PCI procedures worldwide.
Coronary Portfolio
Balloon Catheters
Semi-compliant, non-compliant and ultra high-compliant dilatation catheters for coronary intervention.
Semi-Compliant Dilatation
Evolve-Pro 1.0-1.5mm
FDA SOON- Semi-compliant balloon catheter for small-vessel coronary intervention.
- Designed for precise lesion preparation across the 1.0–1.5 mm size range.
- Supports predictable dilatation performance in complex anatomy.
Expanded Size Range
Evolve-Pro 1.75-4.0mm
FDA SOON- Semi-compliant balloon catheter covering 1.75–4.0 mm diameters.
- Enables physicians to address a broad range of coronary lesions.
- Part of the Evolve-Pro next-generation PTCA catheter platform.
High-Pressure Dilatation
Gambit-Nc 2.0-4.0mm
- Non-compliant balloon catheter for resistant lesion dilatation.
- Delivers high nominal pressure performance when compliance must be controlled.
- Supports effective preparation in calcified and fibrotic lesions.
Next-Generation Compliance
Gambit-NC35 (2.0-4.0mm)
Coming SOON- Ultra high-compliant balloon catheter for advanced coronary applications.
- Expanding the Gambit-NC platform with enhanced compliance characteristics.
- Currently in development — contact us for availability updates.
Coronary Portfolio Overview
- Evolve-Pro 1.0-1.5mm
- Semi-Compliant · FDA SOON
- Evolve-Pro 1.75-4.0mm
- Semi-Compliant · FDA SOON
- Gambit-Nc 2.0-4.0mm
- Non-Compliant
- Gambit-NC35 (2.0-4.0mm)
- Ultra High-Compliant · Coming SOON
Innovation Portfolio
Speciality Portfolio
Innovative specialty devices for complex PCI and advanced interventional procedures.
Speciality Intervention
Panther-Rx
- Speciality portfolio device for advanced interventional procedures.
- Designed to support physicians in complex clinical scenarios.
- Part of Freeway’s innovation pipeline for next-generation PCI.
Drug-Eluting Technology
FreeNova-DEB
- Drug-eluting balloon for targeted therapeutic delivery.
- Supports treatment strategies where stent-free intervention is preferred.
- Advancing Freeway’s portfolio in drug-coated interventional solutions.
Innovation Portfolio Overview
- Panther-Rx
- Speciality Portfolio
- FreeNova-DEB
- Drug-Eluting Balloon
Questions?
Talk to the Freeway team.
For product inquiries, partnerships, or clinical information — our team is ready to help.
Contact Us